16-56363024-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001144.6(AMFR):c.1817C>T(p.Ala606Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000217 in 1,610,860 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001144.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AMFR | NM_001144.6 | c.1817C>T | p.Ala606Val | missense_variant | 14/14 | ENST00000290649.10 | NP_001135.3 | |
AMFR | NM_001323512.2 | c.1913C>T | p.Ala638Val | missense_variant | 15/15 | NP_001310441.1 | ||
AMFR | NM_001323511.2 | c.1532C>T | p.Ala511Val | missense_variant | 14/14 | NP_001310440.1 | ||
AMFR | XM_005255890.5 | c.1532C>T | p.Ala511Val | missense_variant | 14/14 | XP_005255947.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AMFR | ENST00000290649.10 | c.1817C>T | p.Ala606Val | missense_variant | 14/14 | 1 | NM_001144.6 | ENSP00000290649 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000985 AC: 15AN: 152212Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000321 AC: 8AN: 249362Hom.: 0 AF XY: 0.0000445 AC XY: 6AN XY: 134982
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1458530Hom.: 0 Cov.: 31 AF XY: 0.0000152 AC XY: 11AN XY: 724834
GnomAD4 genome AF: 0.0000985 AC: 15AN: 152330Hom.: 0 Cov.: 33 AF XY: 0.0000537 AC XY: 4AN XY: 74498
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 26, 2024 | The c.1817C>T (p.A606V) alteration is located in exon 14 (coding exon 14) of the AMFR gene. This alteration results from a C to T substitution at nucleotide position 1817, causing the alanine (A) at amino acid position 606 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at